TUESDAY, June 27, 2023 (HealthDay News) — An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows. Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, during 48 weeksContinue Reading

WEDNESDAY, June 21, 2023 (HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration. In aContinue Reading

MONDAY, June 19, 2023 (HealthDay news) — Fatty liver disease is increasing rapidly among Americans, outpacing obesity rates across many racial groups and affecting the liver health of millions, a new study reports. Overall, metabolic dysfunction-associated fatty liver disease (MAFLD) in Americans increased 131% during the past three decades, risingContinue Reading

FRIDAY, June 16, 2023 (HealthDay News) — The herbal supplement berberine has become the latest social-media obsession for weight-loss, with some on TikTok calling it “nature’s Ozempic.” Experts don’t agree. “I would say it’s a big exaggeration to call it ‘nature’s Ozempic,’” said Dr. Melinda Ring, executive director of theContinue Reading

THURSDAY, June 15, 2023 (HealthDay News) — Intermittent fasting is all the rage due to the lengthy list of health benefits associated with this style of eating. Now, a new, small study suggests that one type of intermittent fasting — early time-restricted eating — may be key for preventing typeContinue Reading